Cargando…

Coordinating and Assisting Research at the SARS-CoV-2/Microbiome Nexus

Although the COVID-19 pandemic is caused by a single virus, the rest of the human microbiome appears to be involved in the disease and could influence vaccine responses while offering opportunities for microbiome-directed therapeutics. The newly formed Microbiome Centers Consortium (MCC) surveyed it...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7716391/
https://www.ncbi.nlm.nih.gov/pubmed/33262241
http://dx.doi.org/10.1128/mSystems.00999-20
_version_ 1783619150486175744
collection PubMed
description Although the COVID-19 pandemic is caused by a single virus, the rest of the human microbiome appears to be involved in the disease and could influence vaccine responses while offering opportunities for microbiome-directed therapeutics. The newly formed Microbiome Centers Consortium (MCC) surveyed its membership and identified four ways to leverage the strengths and experience of microbiome centers in the response to the COVID-19 pandemic. To meet these needs, the MCC will provide a platform to coordinate clinical and environmental research, assist with practical obstacles, and help communicate the connections between the microbiome and COVID-19. We ask that microbiome researchers join us in these efforts to address the ongoing pandemic.
format Online
Article
Text
id pubmed-7716391
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher American Society for Microbiology
record_format MEDLINE/PubMed
spelling pubmed-77163912020-12-22 Coordinating and Assisting Research at the SARS-CoV-2/Microbiome Nexus mSystems Commentary Although the COVID-19 pandemic is caused by a single virus, the rest of the human microbiome appears to be involved in the disease and could influence vaccine responses while offering opportunities for microbiome-directed therapeutics. The newly formed Microbiome Centers Consortium (MCC) surveyed its membership and identified four ways to leverage the strengths and experience of microbiome centers in the response to the COVID-19 pandemic. To meet these needs, the MCC will provide a platform to coordinate clinical and environmental research, assist with practical obstacles, and help communicate the connections between the microbiome and COVID-19. We ask that microbiome researchers join us in these efforts to address the ongoing pandemic. American Society for Microbiology 2020-12-22 /pmc/articles/PMC7716391/ /pubmed/33262241 http://dx.doi.org/10.1128/mSystems.00999-20 Text en Copyright © 2020 Microbiome Centers Consortium COVID Committee https://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Commentary
Coordinating and Assisting Research at the SARS-CoV-2/Microbiome Nexus
title Coordinating and Assisting Research at the SARS-CoV-2/Microbiome Nexus
title_full Coordinating and Assisting Research at the SARS-CoV-2/Microbiome Nexus
title_fullStr Coordinating and Assisting Research at the SARS-CoV-2/Microbiome Nexus
title_full_unstemmed Coordinating and Assisting Research at the SARS-CoV-2/Microbiome Nexus
title_short Coordinating and Assisting Research at the SARS-CoV-2/Microbiome Nexus
title_sort coordinating and assisting research at the sars-cov-2/microbiome nexus
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7716391/
https://www.ncbi.nlm.nih.gov/pubmed/33262241
http://dx.doi.org/10.1128/mSystems.00999-20